Daniela

@ProfRAScolyer Hard news - thinking of you

Boost Your Pharma Innovation with an Aussie Advantage! At Ab Initio Pharma, we're more than just a CDMO—we're Australia's trusted partner for innovative pharmaceutical development, specialising in complex dosage forms.

Drop by booth 210 to learn how Ab Initio can help you develop clinic ready OINDPs at drug delivery to the lungs 2024 #GMP #formulation #DDL2024

Ab initios CSO, YY talks about advanced nasal drug delivery of RNA using Tetatherix matrix #ddl2024

Ab Initio Pharma featured on BioBeacon ab-initio-pharma.com/news/2024/12/1… @ARCSAustralia #CDMO #GMP

Join Ab Initio at the Targeted Drug Delivery Innovations showcase next week, hosted by the BioNSW and BioMelbourne Network, to learn about how we are innovating in complex dosage form design and manufacture. ab-initio-pharma.com/news/2024/12/1… #BioNSW #GMP #CDMO @aptar

Great to be at the Inaugural NSW Drug Discovery Forum. An exciting day of innovation ahead @AnneCONeill opens the proceedings @MedResearchNSW @Sydney_DDI @duncan_macinnis @MTPConnect_AUS

With only a week to go to AusBio2024, don't forget to book a time to meet with our team to discus all your CDMO needs #GMP #ClinicalTrials #MenInOrange ab-initio-pharma.com/news/2024/10/1…

Meet Lin: Leading Complex Dosage Form GMP Manufacturing at Our CDMO linkedin.com/feed/update/ur… #InnovationInAction #PharmaceuticalExcellence #CDMO

Discover Ab Initio's Mission: Driving Innovation in Therapeutics – An Exclusive Interview at ARCS Australia 2024 youtu.be/ZwFclAqpjz0?si…

Developing next-gen MDIs. Come and talk to the OzUk team about fast tracking your new product to market. Our rapid bench to pivot scale novel propellant development services will give you the upper hand. Exploring the Future of Inhalation Drug Delivery Conference 2024, Parma IT

Meet with the Ab Initio team to discuss our CDMO GMP capabilities for both small molecule and biological OINDP development. Exploring the Future of Inhalation Drug Delivery Conference 2024, Parma Italy.

Ab Initio is proud to launch its ABVANCE Commercialisation Award at the 2024 NSW Drug Discovery Form ab-initio-pharma.com/news/2024/8/28…

Advanced Physicochemical characterisation tools for next generation MDI formulation published in Inhalation Magazine. ab-initio-pharma.com/resources/2024…

@ElonMNews Yes

And Action! Ab Initio talks to @THTpodcast

Ab Initio is #ARCS2024. Come and chat to the team about all your CDMO needs!

Prof Daniela Traini presents some excellent work from the @AbinitioPharma Tetratherix partnership #RDD2024